
Recently FDA approved nasal spray for acute migraine treatment is coming to market.

Exciting news for migraine sufferers! FDA has approved a new nasal spray for acute treatment of migraine. This nasal spray is Zavzpret (zavegepant), the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine. This new and exciting drug provides an alternative option for patients that cannot tolerate oral medications and might be helpful for those with nausea/vomiting, or rapidly progressing migraine. In clinical studies it was shown to provide significant pain releif as early as 15 minutes after the dose. It was well tolerated in clincal trials and the most common reported side effects were taste change, nasal discomfort, and nausea. To learn more follow the link below.
You Might Also Enjoy...

FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.

FDA recently cleared Nerivio for preventive treatment of migraine
The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.

Telehealth: The Advantages of Telemedicine
Struggles to get to the clinic? Trying to reduce your exposure to COVID-19? Telehealth is safe and easy — receive quality care from anywhere.
If you live in Illinois, California, or Florida we could see you via our secure telehealth platform.

Adolescent Migraine: Q & A with Dr. Feoktistov and Migraine.com
A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.

Advanced option in migraine management
Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.
Drug Discovery and Development Interview with Dr. Alex Feoktistov on new treatment options.
Here Dr. Alex Feoktistov discusses migraine symptoms and diagnosis as well acute and prophylactic treatment options.